Negozia Eurofins Scientific - ERFp CFD
Aggiungi a Preferiti- Riepilogo
- Dati Storici
- Eventi
- Conto Economico
- Stato Patrimoniale
- Cash Flow
- Titolarità
Spread | 0.35 | ||||||||
Commissione overnight su posizione lunga
Long position overnight fee
Vai alla piattaforma | -0.024161% | ||||||||
Commissione overnight su posizione corta
Short position overnight fee
Vai alla piattaforma | -0.020283% | ||||||||
Ora commissione overnight | 22:00 (UTC) | ||||||||
Quantità negoziata min | 0.1 | ||||||||
Valuta | EUR | ||||||||
Margine | 20% | ||||||||
Borsa | France | ||||||||
Commissioni per il trading | 0% |
*Information provided by Capital.com
Eurofins Scientific SE ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Chiusura Preced.* | 68 |
Apertura* | 67.55 |
Variazione a 1 Anno* | -25.32% |
Range Giornaliero* | 67.35 - 68.5 |
Range a 52 sett. | 58.06-100.50 |
Volume Medio (10 giorni) | 520.50K |
Volume Medio (3 mesi) | 9.60M |
Capitalizzazione di Mercato | 13.08B |
Rapporto P/E | 16.48 |
Azioni Circolanti | 192.34M |
Ricavi | 6.86B |
EPS | 4.12 |
Dividendi (Rendimento %) | 1.47406 |
Beta | 0.42 |
Prossima Data per Utili | Feb 22, 2023 |
Tutti i dati sono forniti da Refinitiv, ad eccezione dei dati contrassegnati da un asterisco, che sono *dati forniti da Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Chiusura | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Feb 7, 2023 | 68.00 | -0.20 | -0.29% | 68.20 | 68.80 | 67.15 |
Feb 6, 2023 | 70.90 | 0.30 | 0.42% | 70.60 | 71.95 | 70.35 |
Feb 3, 2023 | 70.85 | 2.25 | 3.28% | 68.60 | 71.00 | 68.50 |
Feb 2, 2023 | 68.90 | 2.55 | 3.84% | 66.35 | 69.00 | 66.15 |
Feb 1, 2023 | 65.25 | -0.70 | -1.06% | 65.95 | 66.70 | 65.00 |
Jan 31, 2023 | 65.55 | 0.30 | 0.46% | 65.25 | 65.60 | 64.25 |
Jan 30, 2023 | 65.75 | 0.70 | 1.08% | 65.05 | 65.95 | 64.55 |
Jan 27, 2023 | 65.30 | 0.35 | 0.54% | 64.95 | 65.50 | 64.10 |
Jan 26, 2023 | 64.75 | 0.30 | 0.47% | 64.45 | 64.95 | 63.85 |
Jan 25, 2023 | 63.50 | -0.30 | -0.47% | 63.80 | 63.90 | 62.80 |
Jan 24, 2023 | 64.15 | -0.30 | -0.47% | 64.45 | 65.00 | 63.65 |
Jan 23, 2023 | 64.30 | 0.25 | 0.39% | 64.05 | 64.35 | 63.35 |
Jan 20, 2023 | 63.70 | -0.45 | -0.70% | 64.15 | 64.70 | 63.55 |
Jan 19, 2023 | 64.25 | -1.70 | -2.58% | 65.95 | 66.20 | 63.85 |
Jan 18, 2023 | 66.55 | 0.35 | 0.53% | 66.20 | 67.00 | 66.05 |
Jan 17, 2023 | 65.75 | 1.30 | 2.02% | 64.45 | 65.95 | 64.25 |
Jan 16, 2023 | 64.80 | 0.10 | 0.15% | 64.70 | 65.80 | 64.50 |
Jan 13, 2023 | 64.25 | -0.15 | -0.23% | 64.40 | 64.65 | 63.95 |
Jan 12, 2023 | 64.90 | 1.40 | 2.20% | 63.50 | 65.00 | 63.45 |
Jan 11, 2023 | 63.20 | -1.05 | -1.63% | 64.25 | 64.80 | 62.75 |
Eurofins Scientific Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annuale
- Trimestrale
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ricavi totali | 2536.61 | 2971.42 | 3781.15 | 4562.8 | 5438.8 | 6717.7 |
Ricavi | 2536.61 | 2971.42 | 3781.15 | 4562.8 | 5438.8 | 6717.7 |
Costo dei Ricavi, Totale | 2056.98 | 2414.69 | 3061.3 | 3632.1 | 4026.1 | 4816 |
Profitto Lordo | 479.624 | 556.723 | 719.845 | 930.7 | 1412.7 | 1901.7 |
Totale Costi Operativi | 2178.99 | 2571.85 | 3260.39 | 3989.3 | 4415.2 | 5244.9 |
Costi Commerciali/Generali/Amministr., Totale | 0 | 0 | 0 | |||
Depreciation / Amortization | 122.008 | 157.161 | 199.085 | 357.2 | 389.1 | 428.9 |
Other Operating Expenses, Total | 0.001 | |||||
Risultato d’Esercizio | 357.615 | 399.562 | 520.76 | 573.5 | 1023.6 | 1472.8 |
Interessi Attivi (Oneri), Netti Non Operativi | -68.698 | -42.74 | -59.717 | -93.2 | -97.5 | -97 |
Altro, Netto | 19.91 | 0.001 | -0.001 | -3.1 | -5.9 | -7 |
Utile Netto al Lordo delle Imposte | 308.827 | 356.823 | 461.042 | 477.2 | 920.2 | 1368.8 |
Utile Netto al Netto delle Imposte | 227.465 | 302.341 | 356.061 | 360.3 | 707.2 | 1043.4 |
Partecipazione di Minoranza | -3.509 | -2.074 | 0.358 | 0 | -1 | -0.4 |
Utile Netto al Lordo di Extra Elementi | 223.956 | 300.267 | 356.419 | 360.3 | 706.2 | 1043 |
Totale Elementi Straordinari | -49.959 | -83.496 | -132.476 | -165 | -166.7 | -260 |
Utile Netto | 173.997 | 216.771 | 223.943 | 195.3 | 539.5 | 783 |
Total Adjustments to Net Income | -35.625 | -37.335 | -48.624 | -49.8 | -34.2 | -34.5 |
Reddito a Disposizione di Azionisti Ordinari Esclusi Extra. Elementi | 188.331 | 262.932 | 307.795 | 310.5 | 672 | 1008.5 |
Reddito a Disposizione di Azionisti Ordinari Inclusi Extra. Elementi | 138.372 | 179.436 | 175.319 | 145.5 | 505.3 | 748.5 |
Rettifica Diluizione | 0 | 0 | 0 | |||
Utile Netto Diluito | 138.372 | 179.436 | 175.319 | 145.5 | 505.3 | 748.5 |
Azioni Medie Ponderate Diluite | 169.57 | 179.98 | 183.01 | 186 | 195.9 | 200.6 |
EPS Diluito Esclusi Elementi Straordinari | 1.11064 | 1.4609 | 1.68185 | 1.66935 | 3.43032 | 5.02742 |
Dividends per Share - Common Stock Primary Issue | 0.2 | 0.24 | 0.288 | 0 | 0.68 | 1 |
EPS Diluito Normalizzato | 1.11064 | 1.4609 | 1.68185 | 1.66935 | 3.43032 | 5.02742 |
Q2 2021 | Q4 2021 | |
---|---|---|
Ricavi totali | 3272.3 | 3445.4 |
Ricavi | 3272.3 | 3445.4 |
Costo dei Ricavi, Totale | 2264.2 | 2551.8 |
Profitto Lordo | 1008.1 | 893.6 |
Totale Costi Operativi | 2459 | 2785.9 |
Costi Commerciali/Generali/Amministr., Totale | 0 | 0 |
Depreciation / Amortization | 194.8 | 234.1 |
Risultato d’Esercizio | 813.3 | 659.5 |
Interessi Attivi (Oneri), Netti Non Operativi | -49.6 | -54.4 |
Utile Netto al Lordo delle Imposte | 763.7 | 605.1 |
Utile Netto al Netto delle Imposte | 582.9 | 460.5 |
Partecipazione di Minoranza | -0.4 | 0 |
Utile Netto al Lordo di Extra Elementi | 582.5 | 460.5 |
Totale Elementi Straordinari | -166.9 | -93.1 |
Utile Netto | 415.6 | 367.4 |
Total Adjustments to Net Income | -18.2 | -16.3 |
Reddito a Disposizione di Azionisti Ordinari Esclusi Extra. Elementi | 564.3 | 444.2 |
Reddito a Disposizione di Azionisti Ordinari Inclusi Extra. Elementi | 397.4 | 351.1 |
Utile Netto Diluito | 397.4 | 351.1 |
Azioni Medie Ponderate Diluite | 201 | 200.2 |
EPS Diluito Esclusi Elementi Straordinari | 2.80746 | 2.21878 |
Dividends per Share - Common Stock Primary Issue | 0 | 1 |
EPS Diluito Normalizzato | 2.80746 | 2.21878 |
- Annuale
- Trimestrale
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totale Attivo Corrente | 1579.41 | 1826.58 | 1705.4 | 1604.1 | 2518.2 | 2319 |
Disponibilità Liquide e Investimenti a Breve Termine | 826.098 | 820.357 | 506.246 | 297 | 912.4 | 515.3 |
Cash | 506.019 | 153.293 | 24.599 | 293.4 | 903.7 | 497.9 |
Disponibilità Liquide e Mezzi Equivalenti | 320.079 | 667.064 | 481.647 | 3.6 | 8.7 | 17.4 |
Totale Crediti, Netto | 605.782 | 826.799 | 1043.32 | 1185 | 1389.1 | 1581 |
Accounts Receivable - Trade, Net | 498.014 | 666.828 | 807.233 | 1001.2 | 1193.5 | 1389.2 |
Total Inventory | 39.547 | 51.805 | 66.373 | 79.3 | 157 | 154.2 |
Prepaid Expenses | 22.432 | 37.14 | 42.668 | 42.6 | 59.6 | 68 |
Other Current Assets, Total | 85.554 | 90.477 | 46.796 | 0.2 | 0.1 | 0.5 |
Total Assets | 4129.42 | 5832.31 | 7205.45 | 7823.1 | 8575.5 | 9332.3 |
Property/Plant/Equipment, Total - Net | 506.818 | 685.998 | 1018.01 | 1593.5 | 1574.9 | 1829.9 |
Property/Plant/Equipment, Total - Gross | 1242.93 | 1661.55 | 2151.32 | 3171.5 | 3344.9 | 4020.7 |
Accumulated Depreciation, Total | -736.11 | -975.549 | -1133.31 | -1578 | -1769.9 | -2190.8 |
Goodwill, Net | 1584.64 | 2505.34 | 3418.33 | 3608.8 | 3524.1 | 4115.1 |
Intangibles, Net | 383.209 | 735.12 | 946.918 | 918.2 | 825.1 | 895.7 |
Long Term Investments | 37.527 | 49.584 | 72.626 | 54.5 | 56.6 | 81.7 |
Other Long Term Assets, Total | 37.804 | 29.69 | 44.169 | 44 | 76.6 | 90.9 |
Total Current Liabilities | 710.009 | 1451.89 | 1450.66 | 1581.6 | 1696.4 | 1855.7 |
Payable/Accrued | 230.122 | -0.1 | ||||
Accrued Expenses | 278.76 | 435.633 | 560.803 | 623.7 | 796.6 | 874.6 |
Notes Payable/Short Term Debt | -1.215 | 234.331 | 372.243 | 319.5 | 16.9 | 80.3 |
Current Port. of LT Debt/Capital Leases | 44.734 | 319.9 | 18.832 | 135.3 | 220.7 | 173.5 |
Other Current Liabilities, Total | 157.608 | 255.886 | 266.84 | 271.6 | 383.4 | 404.4 |
Total Liabilities | 2501.94 | 3389.14 | 4536.26 | 4984.5 | 4885.2 | 4684.6 |
Total Long Term Debt | 1340.36 | 1662.1 | 2766.17 | 3086.9 | 2917.2 | 2500.3 |
Long Term Debt | 1331.89 | 1651.54 | 2727.22 | 2646.8 | 2502.4 | 2082.1 |
Capital Lease Obligations | 8.472 | 10.558 | 38.946 | 440.1 | 414.8 | 418.2 |
Deferred Income Tax | 83.911 | 126.352 | 138.557 | 124.5 | 115.3 | 123.6 |
Minority Interest | 129.237 | 38.803 | 52.992 | 59.5 | 26.1 | 29.5 |
Other Liabilities, Total | 238.422 | 109.99 | 127.88 | 132 | 130.2 | 175.5 |
Total Equity | 1627.48 | 2443.17 | 2669.19 | 2838.6 | 3690.3 | 4647.7 |
Common Stock | 1.693 | 1.764 | 1.775 | 1.8 | 1.9 | 1.9 |
Retained Earnings (Accumulated Deficit) | 902.209 | 1457.74 | 1614.03 | 1697.1 | 2853.1 | 3542.7 |
Other Equity, Total | 723.575 | 983.668 | 1053.57 | 1139.9 | 835.3 | 1106.7 |
Total Liabilities & Shareholders’ Equity | 4129.42 | 5832.31 | 7205.45 | 7823.1 | 8575.5 | 9332.3 |
Total Common Shares Outstanding | 169.26 | 176.439 | 177.522 | 179.035 | 190.794 | 192.214 |
Accounts Payable | 206.143 | 231.942 | 231.5 | 278.9 | 322.9 | |
Treasury Stock - Common | -0.184 | -0.2 | 0 | -3.6 |
Jun 2021 | Dec 2021 | |
---|---|---|
Totale Attivo Corrente | 2412.9 | 2319 |
Disponibilità Liquide e Investimenti a Breve Termine | 639.9 | 515.3 |
Disponibilità Liquide e Mezzi Equivalenti | 639.9 | 515.3 |
Totale Crediti, Netto | 1405.3 | 1465.9 |
Accounts Receivable - Trade, Net | 1316 | 1389.2 |
Total Inventory | 169.1 | 154.2 |
Prepaid Expenses | 198.4 | 183.1 |
Other Current Assets, Total | 0.2 | 0.5 |
Total Assets | 8661 | 9332.3 |
Property/Plant/Equipment, Total - Net | 1667.3 | 1829.9 |
Goodwill, Net | 3643.3 | 4115.1 |
Intangibles, Net | 814.9 | 895.7 |
Long Term Investments | 61.5 | 81.7 |
Other Long Term Assets, Total | 61.1 | 90.9 |
Total Current Liabilities | 1758.1 | 1855.7 |
Payable/Accrued | 530.8 | 627.6 |
Accrued Expenses | 44.4 | 31.4 |
Notes Payable/Short Term Debt | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 128.2 | 253.8 |
Other Current Liabilities, Total | 1054.7 | 942.9 |
Total Liabilities | 4581.8 | 4684.6 |
Total Long Term Debt | 2526.8 | 2500.3 |
Long Term Debt | 2526.8 | 2500.3 |
Deferred Income Tax | 116.2 | 123.6 |
Minority Interest | 31 | 29.5 |
Other Liabilities, Total | 149.7 | 175.5 |
Total Equity | 4079.2 | 4647.7 |
Common Stock | 1.9 | 1.9 |
Retained Earnings (Accumulated Deficit) | 3132.2 | 3542.7 |
Other Equity, Total | 945.1 | 1106.7 |
Total Liabilities & Shareholders’ Equity | 8661 | 9332.3 |
Total Common Shares Outstanding | 191.329 | 192.214 |
Treasury Stock - Common | -3.6 |
- Annuale
- Trimestrale
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Reddito Netto/Linea di Partenza | 242.607 | 250.105 | 289.84 | 271.5 | 694.4 | 1056.6 |
Liquidità da Attività Operative | 371.841 | 405.122 | 543.894 | 677.8 | 1223.5 | 1509.9 |
Liquidità da Attività Operative | 141.696 | 175.718 | 223.747 | 395.9 | 426 | 450.7 |
Elementi Non Monetari | 67.414 | 28.645 | 41.124 | 69.6 | 142.8 | 207 |
Cash Taxes Paid | 73.239 | 79.384 | 67.816 | 95 | 94 | 296.7 |
Interessi di Cassa Corrisposti | 55.222 | 45.612 | 59.983 | 93.3 | 67.8 | 168.8 |
Variazioni del Capitale Circolante | -79.876 | -90.121 | -88.622 | -159.2 | -142.5 | -302 |
Liquidità da Attività di Investimento | -391.803 | -1747.09 | -1557.45 | -540.2 | -525 | -1034.2 |
Spese in Conto Capitale | -199.675 | -245.735 | -364.449 | -425.1 | -355.5 | -519.5 |
Altri Elementi del Cash Flow da Investimenti, Totale | -192.128 | -1501.35 | -1193 | -115.1 | -169.5 | -514.7 |
Liquidità da Attività di Finanziamento | 49.903 | 1343.29 | 691.064 | -342.2 | -48.6 | -910.3 |
Elementi del Cash Flow da Finanziamenti | -90.849 | 317.307 | -108.706 | -461.9 | -104.5 | -335.4 |
Total Cash Dividends Paid | -22.452 | -34.912 | -42.645 | -51.1 | ||
Emissione (Dismissione) di Azioni, Netto | 501.118 | 320.049 | 20.041 | 23.4 | 564.8 | 32.2 |
Emissione (Dismissione) di Debiti, Netto | -337.914 | 740.848 | 822.374 | 147.4 | -508.9 | -607.1 |
Effetti Cambi Valutari | 4.674 | -10.969 | 1.465 | 4.1 | -33.9 | 39.1 |
Variazione Netta della Liquidità | 34.615 | -9.641 | -321.023 | -200.5 | 616 | -395.5 |
Amortization | 40.775 | 77.805 | 100 | 102.8 | 97.6 |
Jun 2021 | Dec 2021 | |
---|---|---|
Net income/Starting Line | 578.8 | 1056.6 |
Cash From Operating Activities | 708.6 | 1509.9 |
Cash From Operating Activities | 204.4 | 450.7 |
Non-Cash Items | 192.8 | 304.6 |
Cash Taxes Paid | 139.9 | 296.7 |
Cash Interest Paid | 135.8 | 168.8 |
Changes in Working Capital | -267.4 | -302 |
Cash From Investing Activities | -276.5 | -1034.2 |
Capital Expenditures | -223 | -519.5 |
Other Investing Cash Flow Items, Total | -53.5 | -514.7 |
Cash From Financing Activities | -718.7 | -910.3 |
Financing Cash Flow Items | -150.4 | -335.4 |
Total Cash Dividends Paid | -0.4 | |
Issuance (Retirement) of Stock, Net | 12.6 | 32.2 |
Issuance (Retirement) of Debt, Net | -580.5 | -607.1 |
Foreign Exchange Effects | 14.7 | 39.1 |
Net Change in Cash | -271.9 | -395.5 |
Nome investitore | Tipo investitore | Percentuale in circolazione | Azioni detenute | Variazione azioni | Data partecipazioni | Rating di turnover |
---|---|---|---|---|---|---|
Family (Gilles Martin) | Other Insider Investor | 32.7621 | 63145480 | 0 | 2022-10-24 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.6517 | 5110825 | 497156 | 2022-12-31 | LOW |
Capital Research Global Investors | Investment Advisor | 2.1126 | 4071885 | 2346140 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.772 | 3415358 | 186 | 2022-12-31 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 1.7115 | 3298735 | 10351 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.4551 | 2804489 | 130325 | 2022-12-31 | LOW |
Impax Asset Management Ltd. | Investment Advisor | 1.3688 | 2638300 | 0 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.3249 | 2553659 | 13084 | 2023-01-31 | LOW |
FMR Investment Management (U.K.) Limited | Investment Advisor | 1.3171 | 2538574 | -9500 | 2022-12-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.2415 | 2392913 | 380 | 2022-12-31 | LOW |
1832 Asset Management L.P. | Investment Advisor | 1.1023 | 2124655 | 314999 | 2022-09-30 | LOW |
Mawer Investment Management Ltd. | Investment Advisor | 1.0868 | 2094699 | 38093 | 2022-12-31 | LOW |
Ruane, Cunniff & Goldfarb L.P. | Investment Advisor | 0.9979 | 1923273 | 415107 | 2022-09-30 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.9334 | 1799105 | 64223 | 2022-12-31 | HIGH |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.8623 | 1662046 | -845338 | 2022-12-31 | LOW |
Jupiter Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.7381 | 1422581 | 2545 | 2022-10-31 | LOW |
Union Investment Privatfonds GmbH | Investment Advisor | 0.6808 | 1312181 | -110462 | 2022-09-30 | LOW |
T. Rowe Price International Ltd | Investment Advisor/Hedge Fund | 0.6156 | 1186565 | 69099 | 2022-12-31 | MED |
Credit Suisse Asset Management | Investment Advisor/Hedge Fund | 0.5994 | 1155282 | 1954 | 2022-12-31 | LOW |
Oddo BHF Asset Management S.A.S | Investment Advisor/Hedge Fund | 0.5596 | 1078488 | 0 | 2022-12-31 | LOW |
Perché scegliere Capital.com? I nostri numeri parlano da soli.
Capital.com GroupTraders
Clienti attivi mensilmente
Volume di investimento mensile
Prelevati mensilmente
Calcolatrice di trading
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Eurofins Company profile
Su Eurofins Scientific SE
EUROFINS SCIENTIFIC SE è una compagnia con sede in Lussemburgo impegnata nell'industria dei servizi commerciali di supporto. L'Azienda si unisce ad una parte del gruppo di laboratori che forniscono una gamma di servizi per esami analitici a governi ed alle industrie farmaceutiche, alimentari, ambientali e dei prodotti di consumo. Opera attraverso numerose controllate, come VRL Laboratories negli Stati Uniti, Institut Nehring GmbH in Germania, Agfirst Bay of Plenty, un laboratorio esami sulla maturazione della frutta in Nuova Zelanda, e Megalab SA, un laboratorio di diagnostica clinica in Spagna. È attiva attraverso Ahma Group, Villapharma, Exova laboratori esami ambientali nel Canda Orientale, ASL analises ambientais in Brasile, MVZ fur Laboratoriumsmedizin am Hygiene-Institut Gmbh, Alphora Research, Genoma Laboratory Group, Ana Laboratories Inc, Lifecodexx AG, Gatc Biotech AG, Japan Analytical Chemistry Consultants Co. Ltd. (''Jacc''), Tsing Hua and Ecopro Research K.K. (''Ecopro'') and Craft Technologies.
- IndustriaBusiness Support - Services
- Indirizzo23 val Fleuri, LUXEMBOURG, Luxembourg (LUX)
- Dipendenti57992
- CEOGilles Martin
Industry: | Testing Laboratories |
23 Val Fleuri
LUXEMBOURG
1526
LU
Conto Economico
- Annual
- Quarterly
Altri utenti guardano anche
Sei ancora alla ricerca di un broker di cui ti puoi fidare?
Unisciti agli oltre 500.000+ trader in tutto il mondo che hanno scelto di fare trading con Capital.com